KRYSTAL BIOTECH, INC. (KRYS)
Clinical trial NCT01837862 updates: 1. status: COMPLETED → ACTIVE_NOT_RECRUITING 2. completion date: 2024-04-01 → 2027-12-01 3. primary completion date: 2024-04-01 → 2027-03-01 4. enrollment: 36 → 10 participants 5. enrollment type: ESTIMATED → ACTUAL
📉 **NEGATIVE** • Medium confidence analysis (72%) • Mild negative clinical indicator • Limited downside risk **Sentiment:** Negative (18%) **Content type:** Clinical